Study to Evaluate an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®.
- Study Title
- A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtecֲ®) or Placebo Prior to Daily Injections of Copaxoneֲ®.
- Teva Identifier
- PM014
- ClinicalTrials.gov Identifier
- NCT00240032
- Study Status
- Completed
- Trial Condition(s)
- Multiple Sclerosis
- Interventions
- Drug: glatiramer acetate injection with oral cetirizine hydrochloride | Drug: glatiramer acetate with placebo
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years and older
- Trial Duration
- 10/01/2004 - 07/01/2006
- Phase
- Phase 4
